ACRP-CP Exam Review – GCP Standards, Adverse Events, and Clinical Trial Documentation with Verified Answers

Description: This exam review document covers ACRP-CP questions and verified answers on Good Clinical Practice, adverse events, auditing, and trial compliance. It highlights blinding techniques, informed consent requirements, IRB roles, and investigational product regulations. With thorough coverage of clinical trial documentation and regulatory oversight, it is a comprehensive prep guide for ACRP candidates. Adverse Drug Reaction (ADR) - answerAll noxious and unintended responses to a medicinal product related to any dose (causal relationship is at least a reasonable possibility). Regarding marketed medicinal products: a response to a drug which is noxious and unintended and which occurs at doses normally used in man for prophylaxis, diagnosis, or therapy of diseases or for modification of physiological function Adverse Event (AE) - answerAny untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. (ICH GCP E6 1.2) Audit - answerA systematic and independent examination of trial related activities and documents to determine whether the evaluated trial related activities were conducted, and the data were recorded, analyzed Page1 and accurately reported according to the protocol, sponsor's standard operating procedures (SOPs), Good Clinical Practice (GCP), and the applicable regulatory requirement(s). Audit Trail - answerDocumentation that allows reconstruction of the course of events. Blinding/Masking - answerA procedure in which one or more parties to the trial are kept unaware of the treatment assignment. Single-blinding usually refers to the subject(s) being unaware, and double- blinding usually refers to the subject(s), investigator(s), monitor, and, in some cases, data analyst(s) being unaware of the treatment assignment(s). (ICH GCP E6 1.10) Case Report Form (CRF) - answerA printed, optical, or electronic document designed to record all of the protocol required information to be reported to the sponsor on each trial subject. Clinical Trial/Study - answerAny investigation in human subjects intended to discover or verify the clinical, pharmacological and/or other pharmacodynamic effects of an investigational product(s), and/or to identify any adverse reactions to an investigational product(s), and/or to study absorption, distribution, metabolism, and excretion of an investigational product(s) with the object of ascertaining its safety and/or efficacy. Clinical Trial/Study Report - answerA written description of a trial/study of any therapeutic, prophylactic or diagnostic agent conducted in human subjects, in which the clinical and statistical description, presentations, and analysis are fully integrated into a single report. (ICH GCP E6 1.13) Comparator (Product) - answerAn investigational or marketed product (i.e., active control), or placebo, used as a reference in a clinical trial. Compliance (in relation to trials) - answerAdherence to all the trial related requirements, Good Clinical Practice (GCP) requirements, and the applicable regulatory requirements. Direct Access - answerPermission to examine, analyze, verify, and reproduce any records and reports that are important to evaluation of a clinical trial. Documentation - answerAll records, in any form (including, but not limited to, Page2 written, electronic, magnetic, and optical records, and scans, x-rays, and electrocardiograms) that describe or record the methods, conduct, and/or results of a trial, the factors affecting a trial, and the actions taken. Essential Documents - answerDocuments which individually and collectively permit evaluation of the conduct of a study and the quality of the data produced. Good Clinical Practice (GCP) -